Treatment Outcome

Outcome of Transplantation Using Organs From Donors Infected or Colonized With Carbapenem-Resistant Gram-Negative Bacteria.

Mularoni A, Bertani A, Vizzini G, Gona F, Campanella M, Spada M, et al. Outcome of Transplantation Using Organs From Donors Infected or Colonized With Carbapenem-Resistant Gram-Negative Bacteria. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons//Am J Transplant. 2015;15(10):2674-82.

Acute rejection of a cryopreserved arterial homograft.

Soquet J, Chambon J-, Goffin Y, Jashari R. Acute rejection of a cryopreserved arterial homograft. Cell and tissue banking//Cell Tissue Bank. 2015;16(3):331-3.

Kidney damage during organ recovery in donation after circulatory death donors: data from UK National Transplant Database.

Ausania F, White SA, Pocock P, Manas DM. Kidney damage during organ recovery in donation after circulatory death donors: data from UK National Transplant Database. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons// Am J Transplant. 2012;12(4):932-6.

Risk factors for de novo hepatitis B infection in pediatric living donor liver transplantation.

Rao W, Xie M, Yang T, Zhang J-, Gao W, Deng Y-, et al. Risk factors for de novo hepatitis B infection in pediatric living donor liver transplantation. World journal of gastroenterology// // World J Gastroenterol. 2014;20(36):13159-66.

Renal allograft re-use and herpetic re-infection.

Setyapranata S, Holt SG, Wiggins KJ, Mulley WR, Kerr PG, Landgren AJ, et al. Renal allograft re-use and herpetic re-infection. Nephrology (Carlton, Vic.)// // Nephrology. 2015;20 Suppl 1:17-21.

Human T lymphotropic virus type-1-associated myelopathy manifesting shortly after living-donor renal transplantation.

Nagamine Y, Hayashi T, Kato Y, Horiuchi Y, Tanahashi N. Human T lymphotropic virus type-1-associated myelopathy manifesting shortly after living-donor renal transplantation. Internal medicine (Tokyo, Japan)// Intern Med. 2015;54(1):75-8.

Candida species contamination of preservation fluid-outcome of renal transplantation in 6 patients.

Rodrigues BF, Natario AS, Vizinho RS, Jorge CM, Weigert AL, Martinho A, et al. Candida species contamination of preservation fluid-outcome of renal transplantation in 6 patients. Transplantation proceedings// Transplant Proc. 2013;45(6):2215-9.

Use of kidneys from trypanosoma cruzi-infected donors in naive transplant recipients without prophylactic therapy: the experience in a high-risk area.

Cicora F, Escurra V, Silguero S, Gonzalez IM, Roberti JE. Use of kidneys from trypanosoma cruzi-infected donors in naive transplant recipients without prophylactic therapy: the experience in a high-risk area. Transplantation// Transplantation. 2014;97(1):e3-4.

Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee.

Green M, Covington S, Taranto S, Wolfe C, Bell W, Biggins SW, et al. Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee. Transplantation. 2015;99(2):282-7.

Morbidity and mortality of live lung donation: results from the RELIVE study.

Yusen RD, Hong BA, Messersmith EE, Gillespie BW, Lopez BM, Brown KL, et al. Morbidity and mortality of live lung donation: results from the RELIVE study. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons//Am J Transplant. 2014;14(8):1846-52.

Pages